Mamaroneck, NY, United States of America

Orest William Blaschuk

This inventor holds 2 USPTO granted patents. Top assignee: Zonula, Inc.. Active years: 2019-2020.


% Patents Active = 100.0

Average Co-Inventor Count = 1.3

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Orest William Blaschuk: Innovator in Cell Adhesion Modulation

Introduction

Orest William Blaschuk is a notable inventor based in Mamaroneck, NY (US). He has made significant contributions to the field of biotechnology, particularly in the area of cell adhesion modulation. With a total of two patents to his name, Blaschuk's work has the potential to impact the treatment of various diseases, including cancer.

Latest Patents

Blaschuk's latest patents focus on compounds that act as modulators of cell adhesion. These compounds are derivatives of piperidin-4-amine and can be linked to targeting agents, pharmaceutically active substances, and support materials. The patents disclose methods for enhancing or inhibiting classical cadherin-mediated functions. The compounds developed can be utilized for the treatment or prevention of a variety of diseases, including cancer. Additionally, the patents describe compositions and devices, such as skin patches that incorporate these compounds, along with methods for their synthesis.

Career Highlights

Orest William Blaschuk is associated with Zonula, Inc., where he continues to advance his research and development efforts. His work in the field of biotechnology has positioned him as a key figure in the innovation of therapeutic solutions.

Collaborations

Blaschuk collaborates with Arkadii Vaisburg, contributing to the advancement of their shared goals in biotechnology and innovation.

Conclusion

Orest William Blaschuk's contributions to the field of cell adhesion modulation highlight his innovative spirit and dedication to improving healthcare solutions. His patents represent significant advancements that could lead to new treatments for serious diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…